Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms of Antifolate Efficacy in Arthritis
NCT00000395Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Sep 1996
- Primary completion
- Aug 2002
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial of methotrexate in rheumatoid arthritis (RA) (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoint: Urinary 5-aminoimidazole-4-carboxamide excretion at 6 weeks. Started Sep 1996; status: completed.
02
Drugs
methotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00000395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000395.